Could Two Drugs Be Better Than One for Treating Prostate Cancer?
Combining testosterone-blocking drugs in patients with prostate cancer relapse prevents the spread of cancer better than treatment with a single drug.
University of California San Francisco
Give to UCSF
Why Do Young Women with Multiple Sclerosis Face Health Disparities?
Young Black and Hispanic women with multiple sclerosis fare worse than young white women with the disease. Minority women were more likely to have more advanced disease and faced greater challenges in pregnancy.
Could Bizarre Visual Symptoms Be a Telltale Sign of Alzheimer’s?
Early identification of posterior cortical atrophy (PCA) may have important implications for Alzheimer’s treatment. PCA patients struggle with visual impairments like judging distances, distinguishing between moving and stationary objects and completing tasks like writing and retrieving a dropped item.
Can a Steroid Help Treat Dementia and Schizophrenia?
A little-studied steroid that serves as a building block for hormones like estrogen and testosterone has been shown to enhance learning and memory in a new study by researchers at UC San Francisco.
How Fruit Bats Got a Sweet Tooth Without Sour Health
Fruit bats have a genetic system that controls blood sugar without fail. Learning from that system can help us make better insulin- or sugar-sensing therapies for human patients.
Could a Drug Prevent Hearing Loss from Loud Music and Aging?
A newly-discovered gene may explain how humans go deaf both as they age, and in response to loud noise.
Diagnostic Errors Are Common in Seriously Ill Hospitalized Adults
A study of seriously ill patients from academic medical centers across the country has found that nearly a quarter had a delayed or missed diagnosis.
Survey Shows Physicians Don’t Understand FDA’s Approval Process
Many physicians are unfamiliar with how the Food and Drug Administration’s (FDA) regulates new drugs and medical devices, and they may be under the impression that the data supporting these approvals
For Dementia Prevention, Sleep Quality in Midlife Matters More
Quality of sleep, not quantity, may play a part in the development of dementia decades before symptoms start.
Cancer Researcher Thomas Martin Receives $4.6 million CIRM Grant
UC San Francisco’s Thomas G. Martin, MD, a leading expert in blood cancers, has received a grant of nearly $4.6 million from the California Institute of Regenerative Medicine (CIRM) to produce a CAR T
Study Finds Paxlovid Treatment Does Not Reduce Risk of Long COVID
A team of researchers from UC San Francisco has found that Paxlovid did not reduce the risk of developing long COVID for vaccinated, non-hospitalized individuals during their first COVID-19 infection.